Related Experiment Video
Updated: Apr 19, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Oncogenic tRF-24-O7M8LO9LIM drives lung adenocarcinoma progression by disrupting the CD82/p53 tumor suppressor
Sinan Liu1, Kui Zhu2, Yixuan Wu1
1Department of Laboratory Medicine, Nantong First People's Hospital and The Second Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China.
Abstract:
Transfer RNA-derived small RNAs (tsRNAs), a recently identified class of non-coding RNAs, have been shown to play regulatory roles in various malignancies. However, their functions in lung adenocarcinoma (LUAD) remain largely unexplored. This study aims to elucidate the molecular mechanisms and biological functions of tRF-24-O7M8LO9LIM in LUAD. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to measure the expression levels of tRF-24-O7M8LO9LIM in LUAD patient tissues and lung cancer cell lines. Chi-square tests were performed to analyze the correlations between its expression and clinicopathological characteristics. Kaplan-Meier survival analysis was conducted to assess its prognostic significance. Plasmids for the knockdown and overexpression of tRF-24-O7M8LO9LIM were constructed, and their effects were validated through in vitro cell-based assays-including CCK-8, EdU, colony formation, and Transwell assays-as well as in vivo tumorigenicity experiments in nude mice. A dual-luciferase assay was employed to validate the relationship between tRF-24-O7M8LO9LIM and its downstream target genes. KEGG pathway analysis and western blotting were further used to validate the associated signaling pathways. The results showed that tRF-24-O7M8LO9LIM is highly expressed in LUAD patient tissues and lung cancer cells, correlates with TNM stage and tumor size, and has significant prognostic value. Knockdown of tRF-24-O7M8LO9LIM inhibited cellular proliferation, migration, and invasion in vitro, while simultaneously suppressing tumor growth in vivo. The dual-luciferase assay confirmed the direct binding between tRF-24-O7M8LO9LIM and its downstream target, CD82. KEGG pathway analysis and western blotting experiments demonstrated that tRF-24-O7M8LO9LIM regulates the p53 signaling pathway via CD82. In conclusion, tRF-24-O7M8LO9LIM promotes the progression of LUAD by targeting CD82 to regulate the p53 signaling pathway.
Insights
Transfer RNA-derived small RNAs (tsRNAs) like tRF-24-O7M8LO9LIM promote lung adenocarcinoma (LUAD) progression. This tsRNA targets CD82 to regulate the p53 pathway, impacting tumor growth and patient prognosis.
Area of Science:
- Molecular Biology
- Oncology
- RNA Biology
Background:
- Transfer RNA-derived small RNAs (tsRNAs) are emerging regulators in cancer.
- The role of tsRNAs, specifically tRF-24-O7M8LO9LIM, in lung adenocarcinoma (LUAD) is largely unknown.
Purpose of the Study:
- To investigate the molecular mechanisms and biological functions of tRF-24-O7M8LO9LIM in LUAD.
- To determine the prognostic significance and therapeutic potential of tRF-24-O7M8LO9LIM in LUAD.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) for expression analysis.
- In vitro (cell lines) and in vivo (nude mice) assays for functional validation.
- Dual-luciferase assay, KEGG pathway analysis, and western blotting for mechanism elucidation.
Main Results:
- tRF-24-O7M8LO9LIM is upregulated in LUAD tissues and cells, correlating with advanced TNM stage and tumor size.
- Knockdown of tRF-24-O7M8LO9LIM inhibits LUAD cell proliferation, migration, invasion, and tumor growth.
- tRF-24-O7M8LO9LIM directly targets CD82, regulating the p53 signaling pathway.
Conclusions:
- tRF-24-O7M8LO9LIM acts as an oncogenic tsRNA in LUAD.
- Targeting tRF-24-O7M8LO9LIM or its downstream CD82/p53 pathway may offer therapeutic strategies for LUAD.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes